Difference between revisions of "Comment Resolutions"
Jump to navigation
Jump to search
m |
|||
(45 intermediate revisions by 3 users not shown) | |||
Line 12: | Line 12: | ||
| colspan="4" align="center" style="background:#dddddd" | '''CT Profiles''' | | colspan="4" align="center" style="background:#dddddd" | '''CT Profiles''' | ||
|- | |- | ||
− | | [[Media: | + | | [[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx| CT Small Lung Nodule Screening 2016-06-01]] |
| Public Comment | | Public Comment | ||
− | | | + | | 2016.09 |
− | | [[Media: | + | | [[Media:2018-06-15 v9 QIBA SLN CommentsAndResolutions.xlsx|Public Comment Resolutions 2018-06-15]] |
|- | |- | ||
| [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]] | | [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]] | ||
| Technical Confirmation | | Technical Confirmation | ||
| 2017.02 | | 2017.02 | ||
− | | [https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation | + | | [https://docs.google.com/spreadsheets/d/1cyz0frvELb6Tq1EHjpHxnvjeUxotExnJ3OrKPdIa30U/edit?usp=sharing Technical Confirmation Resolutions 2018-02-25] |
+ | |- | ||
+ | | [[Media:QIBA_CTA_Profile_as_of_2020-March-10.pdf| CT Atherosclerosis 2020-03-10]] | ||
+ | | Public Comment | ||
+ | | 2019.06.03 | ||
+ | | [[Media:QIBA_CTA_Comments_all resolved.xlsx| Public Comment Resolutions 2020-03-12]] | ||
|- | |- | ||
− | | [[Media: | + | | [[Media:QIBA_CT_Lung_Density_Profile_090420-clean.pdf | CT Lung Density 2020-09-04]] |
| Public Comment | | Public Comment | ||
− | | | + | | 2019.10.16 |
− | | ''' | + | | [[Media:QIBA_Lung Density_Comments_resolved.xlsx| Public Comment Resolutions 2020-09-04]] |
+ | |- | ||
+ | | [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-3.pdf|CT Small Lung Nodule Screening 2018-11-18]] | ||
+ | | Technical Confirmation | ||
+ | | 2020.04 | ||
+ | | '''* Resolving Feedback''' | ||
|- | |- | ||
| colspan="4" align="center" style="background:#dddddd" | '''MR Profiles''' | | colspan="4" align="center" style="background:#dddddd" | '''MR Profiles''' | ||
+ | |- | ||
+ | | [[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| MR Elastography 2017-08-15]] | ||
+ | | Public Comment | ||
+ | | 2017.09.15 | ||
+ | | [[Media:MRE_Profile_Public_Comments_2018_02_08.pdf| Public comment Resolutions]] | ||
+ | |- | ||
+ | | [[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| fMRI Sensorimotor 2017-06-19]] | ||
+ | | Public Comment | ||
+ | | 2017.12.31 | ||
+ | | '''Resolving Feedback''' | ||
|- | |- | ||
| [[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf| MR DWI 2019-02-05]] | | [[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf| MR DWI 2019-02-05]] | ||
Line 34: | Line 54: | ||
| [[Media:QIBA DWI Profile-Public Comment--2 Resolutions.pdf| Public Comment Resolutions]] | | [[Media:QIBA DWI Profile-Public Comment--2 Resolutions.pdf| Public Comment Resolutions]] | ||
|- | |- | ||
− | | [[Media: | + | | [[Media:QIBA_DSC-MRI_Stage1_Profile.pdf|MR Dynamic Susceptibility Contrast (DSC-MRI) 2020-01-29]] |
| Public Comment | | Public Comment | ||
− | | | + | | 2020.05.15 |
− | | | + | | [[Media:QIBA_DSC-MRI_Public_Comment_Resolutions_v2020Oct.9.pdf| Public Comment Resolutions]] |
|- | |- | ||
− | | [[Media: | + | | [[Media:QIBA_Profile_MSK-Cartilage-Stage1_Profile.pdf|MR MSK cartilage compositional biomarkers (T1ρ,T2) 2020-05-18]] |
| Public Comment | | Public Comment | ||
− | | | + | | 2020.10.29 |
− | | ''' | + | | '''Resolving Feedback''' |
|- | |- | ||
− | | [[Media: | + | | [[Media:QIBA_DCE-MRI_Profile-Stage_1-Public_Comment.pdf|MR DCE-MRI Quantification (DCEMRI-Q) 2020-10-12]] |
| Public Comment | | Public Comment | ||
− | | | + | | 2021.03.10 |
− | | ''' | + | | '''Resolving Feedback''' |
|- | |- | ||
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles''' | | colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles''' | ||
+ | |- | ||
+ | | SPECT Ioflupane in Neurodegenerative Disease v1.1 | ||
+ | | Public Comment | ||
+ | | 2016.12.31 | ||
+ | | [[Media: SPECT Profile Response to Public Comments.v2017 06 06.xlsx | Public Comment Resolutions 2017-06-06]] | ||
|- | |- | ||
| [[Media:QIBA_AmyloidPET_15June2017.pdf| PET Amyloid 2019-06-15]] | | [[Media:QIBA_AmyloidPET_15June2017.pdf| PET Amyloid 2019-06-15]] | ||
| Public Comment | | Public Comment | ||
| 2017.09.15 | | 2017.09.15 | ||
− | | | + | | [[Media:QIBA_PET_Amyloid Comments_all resolved.xlsx| Public Comment Resolutions 2018-05-02]] |
+ | |- | ||
+ | | [[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]] | ||
+ | | Public Comment | ||
+ | | n/a | ||
+ | | v2.0 is an update of v1.0 without additional public comment | ||
|- | |- | ||
− | | [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| 99mTC | + | | [[Media:QIBA_99mTC SPECT 2020-05-12.pdf| SPECT 99mTC 2020-05-12]] |
| Public Comment | | Public Comment | ||
| 2020.02.03 | | 2020.02.03 | ||
− | | ''' | + | | [[Media:QIBA_99mTC SPECT Comments_2020-08-11-final.xlsx| Public Comment Resolutions 2020-08-11]] |
+ | |- | ||
+ | | colspan="4" align="center" style="background:#dddddd" | '''Ultrasound Profiles''' | ||
+ | |- | ||
+ | | [[Media:QIBA_US_SWS_Profile_10.21.19.pdf|US Shear Wave Speed for Liver Fibrosis 2019-10-21]] | ||
+ | | Public Comment | ||
+ | | 2019.12.18 | ||
+ | | [[Media:QIBA_US_SWS_Comments_2021-02-06-final.xlsx| Public Comment Resolutions 2021-02-06]] | ||
+ | |- |
Revision as of 18:48, 10 March 2021
Comments received during Public Comment, Technical Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.